Iran rules out ballistic missile restrictions in resumed U.S. nuclear talks
Iran’s Foreign Minister Abbas Araghchi has firmly ruled out any discussion of the country’s ballistic missile capabilities in the newly resumed, O...
Uganda has launched a trial vaccination program for the Sudan strain of Ebola as confirmed cases rise to three. With no approved vaccine for this strain, the trial aims to protect communities and strengthen outbreak response, according to the WHO.
Uganda has launched a trial vaccination program for the strain of Ebola responsible for the country’s latest outbreak, according to the World Health Organization (WHO), as the number of confirmed cases has increased to three.
The East African nation reported an Ebola outbreak in its capital, Kampala, last week, initially identifying a single case—a nurse who passed away on January 29.
Ministry of Health spokesperson Emmanuel Ainebyoona informed Reuters on Monday that the total number of cases has now risen to three, with two additional infections found among the deceased nurse’s family members.
In a post on X later that day, WHO’s Africa director, Matshidiso Moeti, confirmed that Uganda had also initiated a clinical trial for a vaccine targeting the Sudan strain of Ebola.
At present, there is no approved vaccine for this particular strain. The available vaccine is designed to combat the Zaire strain, which has caused a recent outbreak in the neighboring Democratic Republic of Congo.
Bruce Kirenga, head of the Makerere Lung Institute—the research organization conducting the trial—told local media that the vaccine was developed by the International Aids Vaccine Initiative (IAVI), and approximately 2,460 doses had been received for the program.
According to Uganda’s health ministry, the trial is focused on vaccinating individuals who have been in contact with confirmed cases.
The United States and Azerbaijan signed a strategic partnership in Baku on Tuesday (10 February) encompassing economic and security cooperation as Washington seeks to expand its influence in a region where Russia was once the main power broker.
Greek Prime Minister Kyriakos Mitsotakis arrived in Ankara on Wednesday, where Turkish President Recep Tayyip Erdoğan held an official welcoming ceremony at the Presidential Palace, marking the start of high-level talks between the two NATO allies.
Europe heads into the Munich Security Conference, 13 February, amid deepening unease over U.S. policy, as President Donald Trump’s hard-line stance on defence, trade and territory fuels doubts about Washington’s long-term commitment to transatlantic security.
The European Union is preparing a further expansion of its sanctions against Russia, with Central Asia emerging for the first time as a distinct point of focus.
A senior adviser to Iran’s Supreme Leader said on Tuesday that negotiations with the United States must remain focused on the nuclear issue and be grounded in realism, as Washington and Tehran prepare to resume talks mediated by Oman.
Measles cases across Europe and Central Asia fell sharply in 2025 compared to the previous year but health officials have warned that the risk of fresh outbreaks remains unless vaccination gaps are urgently addressed.
A Florida university has become a new hotspot in a widening U.S. measles outbreak, with health officials confirming multiple infections and hospitalisations.
The World Health Organization has added the Nipah virus to its list of the world’s top 10 priority diseases, alongside COVID-19 and the Zika virus, warning that its epidemic potential highlights the global risk posed by fast-spreading outbreaks.
Belgian authorities are examining suspected cases of infants falling ill after consuming recalled Nestle baby formula, amid warnings that confirmed infections may be underestimated due to limited testing requirements.
Two Nipah infections involving health workers in India have triggered heightened screening across Southeast Asia as authorities move to prevent the high fatality virus from spreading beyond the country.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment